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Viral replication signiﬁcantly alters the gene expression landscape of infected cells. Many of these
changes are driven by viral manipulation of host transcription or translation machinery. Several
mammalian viruses encode factors that broadly dampen gene expression by directly targeting
messenger RNA (mRNA). Here, we highlight how these factors promote mRNA degradation to globally
regulate both host and viral gene expression. Although these viral factors are not homologous and use
distinct mechanisms to target mRNA, many of them display striking parallels in their strategies for
executing RNA degradation and invoke key features of cellular RNA quality control pathways. In some
cases, there is a lack of selectivity for degradation of host versus viral mRNA, indicating that the purposes
of virus-induced mRNA degradation extend beyond redirecting cellular resources towards viral gene
expression. In addition, several antiviral pathways use RNA degradation as a viral restriction mechanism,
and we will summarize new ﬁndings related to how these host-encoded ribonucleases target and
destroy viral RNA.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
A recurring theme in many virus–host interactions is the attempt
to restrict gene expression. For the cell, such restriction is used as an
antiviral mechanism. For the virus, dampening gene expression can
be used to liberate cellular resources, escape immune detection, and
regulate viral transcript abundance. This review will focus on how
this virus–host battle plays out at a terminal stage of the gene
expression cascade – that of messenger RNA (mRNA) degradation –
as research over the last several years has revealed how regulating
mRNA demise plays important and unexpected roles in the lifecycles
of diverse viruses. We will highlight how unrelated viruses have
evolved remarkably similar strategies to promote mRNA degradation,
even though the degree and nature of selectivity often differ. Also
notable is the apparent viral mimicry of some cellular RNA degrada-
tion pathways, which themselves have emerging antiviral roles.
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Overview of basal and specialized mRNA degradation
Rates of individual mRNA degradation in a cell vary widely, and
are regulated by a large cohort of RNA binding proteins that control
translation, localization, and access to the decay machinery. However,
nearly all mRNAs are protected by a 507-methyl-guanosine (7mG) cap
and a 30 poly(A) tail, features that physically protect the mRNA ends
from exonucleolytic decay, and also serve to recruit translation
initiation machinery. Circularization of mRNA during translation
through interactions between cap-binding and poly(A) tail binding
proteins adds additional protection from cellular decay enzymes.
Degradation of mRNAs at the end of their translational life,
termed basal decay, occurs in several stages but initiates with gradual
shortening of the poly(A) tail, termed deadenylation, by cellular
decay factors including the Ccr4-Not complex and poly(A)-speciﬁc
ribonuclease (PARN). Poly(A) tail length is a determinate of mRNA
stability and translational competence, and thus is tightly controlled
(Eckmann et al., 2011). Deadenylation triggers removal of the 7mG
cap by the decapping complex Dcp1/2 and its activators. These
events expose the mRNA to rapid exonucleolytic degradation, pri-
marily from the 50 end by Xrn1, but also from the 30 end by the
exosome and Dis3L2 (Fig. 1) (Gallouzi and Wilusz, 2013).
The fact that basal decay proceeds from the mRNA ends allows for
tight control of mRNA degradation, as removal of the poly(A) tail and
cap is regulated, rate-limiting, and in some cases may even be
reversible (Schoenberg and Maquat, 2009; Weill et al., 2012). How-
ever, the subsequent exonucleolytic decay of the message body is
rapid and irreversible. To maintain transcriptome ﬁdelity cells also
need to immediately destroy cytoplasmic mRNAs recognized as
aberrant. In such cases, the strategy for degradation differs funda-
mentally from that of basal decay, in that mRNAs are usually cleaved
internally by an endonuclease rather than gradually trimmed from
either end.
The best-characterized cellular mRNA quality control (QC) pathway
is nonsense-mediated decay (NMD), which identiﬁes mRNAs with
premature termination codons (PTC) (Fig. 1) (Popp and Maquat, 2013).
Numerous cellular factors comprise the NMD machinery, but the
central NMD regulator is UPF1, whose activation leads to translational
repression and accelerated degradation of the PTC-containing mRNA.
During NMD in mammals, this rapid mRNA degradation is triggered
by endonucleolytic cleavage of the mRNA by the Smg6 endonuclease
at the site of the PTC, followed by degradation of the cleaved
fragments by components of the basal mRNA decay machinery such
as Xrn1 (Lykke-Andersen et al., 2014; Schweingruber et al., 2013).
Other RNA QC pathways similarly recognize aberrant translation
events such as stalled or non-terminating ribosomes indicative of
RNA errors and lead to inactivation of the mRNA in question through
endonucleolytic cleavage (Inada, 2013).
Viral endonucleases and decapping enzymes bypass regulatory
steps of mRNA decay
All viruses known to drive widespread mRNA degradation do so
by causing internal endonucleolytic cleavages or by directly removing
the mRNA 50 cap structure (Fig. 1). Regardless of the precise
mechanisms used, these strategies have in common one salient
feature: they bypass the rate-limiting and regulated steps of dead-
enylation and cellular decapping, much like the cellular RNA QC
pathways. This ensures both immediate translational inactivation
and exposure of the mRNA ends to the processive cellular exonu-
cleases. However, unlike the tightly regulated cellular QC endonu-
cleases, during infection a large proportion of the cytoplasmic mRNA
population is targeted for cleavage. This allows the viruses to broadly
restrict gene expression, as mRNAs they target are degraded much
more rapidly than they would be if they entered the basal decay
pathway. Furthermore, akin to cellular pathways like NMD, viruses
that cleave mRNAs often usurp Xrn1 to complete the degradation
process (Gaglia et al., 2012).
Four classes of viruses have been shown to cause endonucleolytic
cleavage of mRNAs for the purpose of restricting gene expression
(Table 1). The alpha-herpesviruses, gamma-herpesviruses, and inﬂu-
enza A viruses encode non-homologous endonucleases that cleave
mRNAs directly. SARS coronavirus (SARS CoV) does not encode an
RNA cleaving enzyme, but nonetheless activates an as yet unknown
cellular endonuclease to cleave mRNAs. In each examined case, viral
speciﬁcity for mRNAs (as opposed to other types of RNA) is conferred
by the act of translation or recognition of mRNA features associated
with translational competence, similar to cellular RNA QC pathways
(Covarrubias et al., 2011; Kamitani et al., 2009; Read, 2013).
DNA virus-encoded endonucleases
Alpha-herpesviruses such as herpes simplex-1 (HSV-1) express a
FEN1-like nuclease termed virion host shutoff protein (vhs) that is
directed to mRNAs through interactions with the translation
Fig. 1. Overview of cellular and viral decay pathways. Basal decay begins with the rate-limiting step of deadenylation, followed by decapping and exonucleolytic degradation
of the mRNA body. Quality control decay pathways such as NMD recognize aberrant mRNAs during translation, including the presence of premature termination codons
(PTC), and induce endonucleolytic cleavage, whereupon the fragments are degraded by exonucleases. Virus-induced decay also bypass early steps of the basal decay pathway
and involves internal cleavage of mRNAs, usually in a translation-linked manner, which is followed by degradation by host exonucleases.
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initiation factors eIF4H and eIF4AI/II (Feng et al., 2005; Page and
Read, 2010). If this interaction is disrupted but the catalytic endonu-
clease activity remains intact, no host shutoff occurs, indicating that
recruitment of vhs to the pool of translating mRNAs is crucial to its
ability to dampen gene expression (Feng et al., 2005; Sarma et al.,
2008; Shiﬂett and Read, 2013). In vitro, vhs lacks speciﬁcity, cleaving
mRNAs and non-mRNAs indiscriminately, as well as anywhere along
the RNA (Read, 2013). However, in cells or in the presence of cell
extracts, vhs preferentially cuts mRNAs at unstructured sites within
the 50 UTR or near the start codon of capped mRNAs (Karr and Read,
1999; Shiﬂett and Read, 2013). Cut sites also cluster downstream of
the encephalomyocarditis virus (EMCV) internal ribosome entry site
(IRES), which recruits the vhs-targeting translation factors eIF4AI/II,
but not near the more minimal Cricket Paralysis virus (CrPV) IRES
that recruits the ribosome in the absence of eIF4F (Shiﬂett and Read,
2013). Further support for the hypothesis that vhs accesses its
cleavage sites during translation initiation comes from experiments
showing that speciﬁc cleavage sites can be repressed or enhanced by
mutating the target mRNA start codon or enhancing its Kozak
consensus context, respectively (Read, 2013; Shiﬂett and Read,
2013). However, the observation that an mRNA with a cap-
proximal hairpin structure that prevents 40S recruitment remains
fully susceptible to vhs cleavage argues against an absolute require-
ment for ribosomal scanning (Gaglia et al., 2012). One possibility is
that assembly of the eIF4F complex on the mRNA cap induces local
RNA structure remodeling that creates vhs accessible sites, but that
more directed cleavages occur near the start codon during the
process of 40S scanning. After vhs-induced cleavage, the resulting
30 mRNA fragments are degraded by the cellular Xrn1 exonuclease
(Gaglia et al., 2012).
Gamma-herpesviruses encode a viral endonuclease that, although
not homologous to alpha-herpesvirus vhs, also broadly targets cyto-
plasmic mRNAs for cleavage and subsequent degradation. This protein,
termed SOX in Kaposi’s sarcoma-associated herpesvirus (KSHV),
muSOX in murine gamma-herpesvirus 68 (MHV68), and BGLF5 in
Epstein–Barr virus (EBV), is a member of the PD(D/E)XK restriction
endonuclease superfamily. The SOX ortholog in HSV-1 was originally
shown to have DNase activity involved in viral DNA genome replica-
tion (Wilkinson and Weller, 2003), a function it presumably retains in
all herpesviruses in addition to the gamma-herpesvirus-speciﬁc
mRNA degradation activity. Both the DNA and RNA cleavage activities
of the protein require the same catalytic core region (Bagneris et al.,
2011; Glaunsinger et al., 2005). Although SOX speciﬁcally targets
translationally competent mRNAs, active translation is not a require-
ment for target recognition and the molecular features that direct SOX
to mRNAs remain unknown. SOX-induced mRNA cleavage occurs at
one or more speciﬁc, but as-yet poorly sequence deﬁned RNA
elements (Z50 nt) that can be present anywhere along the length
of a target (Covarrubias et al., 2011; Gaglia et al., 2012). Although a
SOX targeting element can confer a new cleavage event if moved to a
different location on an mRNA, it is incapable of directing cleavage by
SOX if introduced into noncoding RNAs transcribed by RNA polymer-
ase I or III (Gaglia et al., 2012). Similar to vhs, recombinant SOX and
BGLF5 display relaxed RNA targeting speciﬁcity in vitro (Bagneris et al.,
2011; Buisson et al., 2009), indicating that additional mRNA-speciﬁc
features must be required for SOX recruitment in cells. Single function
mutants of SOX and muSOX that are defective for mRNA cleavage but
retain their DNase activity have mutations that map to regions outside
the catalytic core on the protein surface (Bagneris et al., 2011;
Covarrubias et al., 2009; Glaunsinger et al., 2005). Furthermore, the
crystal structure of BGLF5 revealed the presence of a ﬂexible “bridge”
domain that crosses the active site and contains residues involved in
host shutoff (Buisson et al., 2009; Horst et al., 2012). These non-
catalytic regions may therefore function in targeting the gamma-
herpesvirus SOX orthologs to translationally competent mRNAs,
perhaps through interactions with speciﬁc mRNA binding proteins.
Similar to vhs, SOX-cleaved mRNAs subsequently enter the cellular
mRNA decay pathway and are degraded by Xrn1 (Covarrubias et al.,
2011; Gaglia et al., 2012).
RNA virus-encoded endonucleases
The PA-X protein of inﬂuenza A virus (IAV) is a recently
discovered mRNA endonuclease involved in restricting host gene
expression (Jagger et al., 2012). It is expressed by a ribosome
frameshifting event during translation of the PA subunit of the
viral RNA-dependent RNA polymerase (RdRp), itself an endonu-
clease that is responsible for cap snatching in the nucleus. Like the
gamma-herpesvirus SOX orthologs (and many endonucleases
involved in cap snatching), PA-X is a member of the PD(D/E)XK
nuclease family. PA-X retains the N-terminal PA endonuclease
domain but contains a distinct C-terminus that augments the
cellular mRNA degradation activity of the protein via unknown
mechanisms (Desmet et al., 2013; Jagger et al., 2012). One
possibility is that C-terminal sequences are involved in directing
PA-X to its mRNA targets. In this regard, it would be interesting to
determine whether PA-X targeting is linked to translation and
feeds into the cellular Xrn1 decay pathway, as has been shown for
other viral mRNA restriction factors.
SARS CoV expresses a host shutoff factor, nsp1, that binds the
40s ribosome, simultaneously inducing cleavage of mRNAs and
inactivating the ribosome (Huang et al., 2011; Kamitani et al.,
2009). By binding the 40s ribosome, nsp1 is recruited to all
translationally competent mRNAs, allowing for broad targeting of
cellular transcripts. Nsp1 itself does not possess detectable intrin-
sic nuclease activity, suggesting that nsp1-induced mRNA cleavage
may instead occur through activation of a cellular RNA surveillance
pathway (Almeida et al., 2007; Huang et al., 2011). Candidate
pathways include those involved in monitoring translational
efﬁciency, given that the nsp1–40S interaction leads to ribosome
inactivation in addition to mRNA cleavage (Narayanan and Makino,
2013). For example, the no-go decay pathway degrades mRNAs
with stalled ribosomes, albeit using a currently unknown endo-
nuclease (Harigaya and Parker, 2010). As has been observed for
cellular QC pathways like NMD as well as the herpesviral endo-
nucleases, degradation of the cleaved mRNAs in nsp1-expressing
cells is executed by Xrn1 (Gaglia et al., 2012).
Viral decapping enzymes
Poxviruses and African Swine Fever Virus (ASFV) are the only
viruses known to encode decapping enzymes. Similar to cellular
Table 1
Viral endonucleases that broadly restrict gene expression.
Virus Host shutoff factor Nuclease superfamily Targeting mechanism Cleavage location Viral mRNAs
HSV-1 vhs FEN-1 Binds translation factors eIF4F 50 UTR, near cap Susceptible (early)
KSHV, MHV68, EBV SOX, muSOX, BGLF5 PD(D/E)XK Unknown At targeting sequence Susceptible
Inﬂuenza A PA-X PD(D/E)XK Unknown Unknown Unknown
SARS-CoV Nsp1 Not applicable Binds 40s ribosome ribosome binding site Protected by 50 leader sequence
Vaccinia virus D10, D9 Nudix domain decappers Cap-binding 50 cap Susceptible
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decappers, the vaccinia virus (VACV) D9 and D10 decapping proteins
contain a Nudix hydrolase domain that is essential for cleaving the
7mGpppN cap between the alpha- and beta-phosphates (Parrish et
al., 2007; Shors et al., 1999; Souliere et al., 2009). The ASFV decapping
enzyme g5R also contains a Nudix domain essential for decapping.
Both the VACV and ASFV decapping enzymes are inhibited in the
presence of excess uncapped RNAs, but only the VACV D10 enzyme is
also inhibited by cap analogs (Parrish et al., 2009). This suggests that
g5R recognizes its substrates by binding the RNA body rather than
the cap, whereas VACV D10 binds both the methylated cap and the
RNA body (Parrish et al., 2009). Extensive site-directed mutagenesis
of VACV D10 identiﬁed eight amino acids in the catalytic core of D10
important for decapping activity and showed that D10 recognizes
the cap in a manner distinct from other characterized cap binding
proteins (Souliere et al., 2010).
It is unknown why poxviruses expresses two functional decap-
ping enzymes, although the reason may be linked to the fact that D9
is expressed early during infection while D10 is expressed later, after
DNA replication. Additionally, there are some differences between
the two enzymes, including the observations that D9 requires longer
RNA substrates than D10, and D9 mutants have less pronounced
phenotypes than D10 mutants (Parrish and Moss, 2006, 2007).
Therefore, the kinetic and functional requirements for decapping
may vary as VACV infection progresses. As decapping renders the 50
end of an mRNA unprotected, it is likely that D9 and D10 cleaved
mRNAs are digested by Xrn1, similar to the cleavage products
induced by vhs, SOX, and nsp1. Interestingly, a recent RNAi screen
suggested a positive role for Xrn1 in VACV replication (Sivan et al.,
2013), perhaps indicating that Xrn1-mediated RNA degradation plays
an important role in the viral lifecycle.
Viral mRNAs do not broadly escape inactivation
It is often presumed that restriction of cellular gene expression
during infection serves in part to divert resources for the selective
enhancement of viral gene expression. However, in each of the above
documented examples there is not a clear escape mechanism to
broadly protect viral mRNAs from inactivation. Instead, these viruses
may beneﬁt from reduced transcript levels during infection, either
because mRNA inactivation helps them regulate their gene expres-
sion kinetics or other aspects of the viral lifecycle.
During VACV infection, the decapping enzymes D9 and D10 fail to
discriminate between viral and cellular mRNA. Targeting viral
transcripts is proposed to help facilitate transitions between the
classes of gene expression, as D10 mutants exhibit delayed onset of
early and late viral gene expression (Liu et al., 2014; Parrish and
Moss, 2006). Similarly, alpha- and gamma-herpesviral mRNAs are
inherently susceptible to endonucleolytic cleavage. During HSV-1
infection, vhs plays an important role in mediating the effective
transition between the expression of immediate-early (α), early (β),
and late (γ) genes (Read, 2013). There are some discrepancies in the
ﬁeld as to exactly which viral mRNAs are susceptible to vhs-mediated
degradation during infection. Some data suggest that only α mRNAs
are targeted (Shu et al., 2013; Taddeo et al., 2013), while data from
other groups indicate that α, β, and even some γ mRNAs are
susceptible to degradation by vhs (Kwong and Frenkel, 1987;
Oroskar and Read, 1987, 1989). Regardless of the extent of viral
mRNA degradation, targeting of viral mRNAs by vhs helps facilitate
the transition between viral gene classes as infection progresses.
Furthermore, during infection with a vhs null virus, γ mRNAs are
excluded from polysomes due to ‘translational overload’, whereby
the capacity of the translation machinery becomes overwhelmed due
to an excess of mRNAs produced earlier in infection (Dauber et al.,
2014). This conﬁrms the long-held hypothesis that host shutoff is a
means of liberating translational machinery for viral use—with the
twist that both host and viral transcripts must be degraded to ensure
efﬁcient translation of γ mRNAs. Further contributing to the robust
accumulation of γ proteins is the inactivation of vhs later during
infection by the virion proteins VP16, VP22, and UL47 (Read, 2013;
Shu et al., 2013). All three are packaged into the viral particle along
with vhs, and it has been suggested that sequestering vhs in this
complex represents an early stage in virion assembly and protects
mRNAs from cleavage late in infection. Thus, despite widespread viral
mRNA susceptibility, vhs targeting of mRNAs appears temporally
controlled.
The SOX homologs in MHV68 (muSOX) and EBV (BGLF5) have
also been shown to target viral mRNAs for cleavage (Abernathy
et al., 2014; Horst et al., 2012). Unlike vhs, however, there is no
indication that SOX or its orthologs are inactivated as infection
progresses. During MHV68 infection, muSOX broadly targets viral
mRNAs from all three kinetic classes, which generally leads to
corresponding decreases in viral protein levels in each class
(Abernathy et al., 2014). Thus, unlike HSV-1 infection, the targeting
of viral mRNAs during gamma-herpesvirus infection is not a
mechanism to redirect the translation machinery towards viral
genes. This also suggests that translation factors do not become
limiting during MHV68 infection. Selective inactivation of the
mRNA degradation activity of muSOX results in altered protein
composition of progeny virions, which ultimately impacts subse-
quent rounds of infection by favoring lytic cycle entry over latency.
The mutant also exhibits replication defects in multiple cell types
(Abernathy et al., 2014; Richner et al., 2011). Deletion of BGLF5
during EBV infection also results in accumulation of several viral
proteins, as well as causes nuclear egress defects (Feederle et al.,
2009). However, because BGLF5 has dual roles in viral genome
maturation and mRNA degradation and the BGLF5 mutant virus
lacks both functions, it is not possible to ascribe the above
phenotypes solely to a defect in host shutoff. Nonetheless, these
data support the hypothesis that degradation of viral mRNA during
gamma-herpesvirus infection plays important roles in regulating
gene expression and subsequent viral particle composition.
Unlike herpesviral and poxviral mRNAs, SARS CoV transcripts are
categorically resistant to nsp1-induced cleavage and degradation. This
protection is due to the presence of a protective 50 leader sequence
present on all viral mRNAs, although the mechanism of protection
remains unclear (Huang et al., 2011). However, while CoV mRNAs
escape endonucleolytic cleavage, they do not escape nsp1-induced
ribosome inactivation, raising the issue of what advantage is con-
ferred by the protective sequence (Huang et al., 2011; Lokugamage
et al., 2012). One likely possibility is that ribosome inactivation is not
complete, and consequently viral gene expression is not as severely
impacted as cellular gene expression. Whether this represents a
mechanism to ﬁne tune viral protein synthesis in a manner important
for the viral lifecycle in vivo remains an interesting question for future
investigation.
Downstream consequences of virus-induced cytoplasmic
mRNA degradation
Degradation of mRNA has recently been shown to be highly
interconnected with many other cellular processes including tran-
scription, mRNA export, and translation (Braun and Young, 2014; Huch
and Nissan, 2014). It is thus likely that the broad virus-induced mRNA
decay described above will result in changes to other RNA processes as
well. One example of this is altered mRNA 30 end processing in the
nucleus that occurs as a consequence of enhanced mRNA decay in the
cytoplasm (Fig. 2). Poly(A) binding protein (PABPC) normally binds to
poly(A) tails of mRNAs in the cytoplasm, where it contributes to the
regulation of mRNA stability and enhances translation. However,
PABPC becomes strongly relocalized to the nucleus in cells expressing
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SOX, muSOX, BGLF5, vhs, PA-X or nsp1 (Arias et al., 2009; Khaperskyy
et al., 2014; Kumar and Glaunsinger, 2010; Lee and Glaunsinger, 2009;
Park et al., 2014). Nuclear import occurs because within its RNA
binding domains, PABPC harbors noncanonical nuclear localization
signals (NLS) that are masked when it is bound to poly(A) tails in the
cytoplasm. However, during accelerated mRNA degradation by these
viral proteins, PABPC is released from poly(A) tails, exposing its NLS for
interaction with the nuclear import machinery (Kumar et al., 2011).
Such aberrant accumulation of PABPC in the nucleus causes hyper-
adenylation of nascent transcripts by cellular poly(A) polymerase II
(Kumar and Glaunsinger, 2010; Lee and Glaunsinger, 2009). These
hyperadenylated mRNAs are retained in the nucleus, presumably
because they are recognized as aberrant by the nuclear RNA QC
machinery. This process thus contributes to the overall magnitude of
host shutoff, as the cytoplasm cannot be efﬁciently repopulated with
newly transcribed mRNAs.
Accelerated cytoplasmic decay may also lead to inhibition of
stress granule (SG) formation. SGs are storage sites for transla-
tionally stalled mRNAs, and form in response to translational
arrest that often occurs during viral infection (Valiente-
Echeverria et al., 2012). Many viruses have evolved mechanisms
to block their formation, presumably to ensure continued transla-
tion of viral proteins. Viral nucleases can contribute to SG
dispersal, presumably through the bulk reduction of mRNAs
needed to nucleate SG formation. For example, along with several
other IAV-encoded proteins, the endonuclease PA-X was recently
identiﬁed as a potent inhibitor of SGs (Khaperskyy et al., 2014). PA-
X-mediated SG inhibition coincides with PABPC relocalization,
hinting at a link between host shutoff and SG dynamics. Similarly,
the vhs nuclease of HSV-2 is required for the SG disruption that
occurs during HSV-2 infection (Finnen et al., 2014). However, vhs
has also been implicated in translational enhancement of viral late
genes (a role separable from its RNase activity) (Dauber et al., 2011,
2014), making it difﬁcult to ascribe the SG dispersal phenotype
solely to mRNA depletion. Nonetheless, viral mRNA-targeting
nucleases provide a unique system to dissect the link between
mRNA decay and SG assembly.
Contributions of virus-induced mRNA degradation towards immune
evasion
Widespread dampening of gene expression during infection is
presumed to contribute to viral immune evasion, both by inhibiting
expression of cellular immune regulatory genes and by reducing the
abundance of viral antigens available for detection. Indeed, viruses
containing mutations in HSV-1 vhs, MHV68 muSOX, coronavirus
nsp1, and VACV D10 exhibit more severe phenotypes in a mouse
model of infection than in cultured cells (Liu et al., 2014; Richner
et al., 2011; Smiley, 2004; Zust et al., 2007), suggesting mRNA
degradation contributes to virulence. Activation of the innate
immune response leads to expression of hundreds of genes involved
in establishing an antiviral state. Vhs suppresses the expression of
several of these genes including tetherin and viperin, which would
normally act to restrict HSV-1 infection (Shen et al., 2014; Zenner
et al., 2013), as well as many pro-inﬂammatory cytokines (Suzutani
et al., 2000). Some of the differences in the in vivo infectivity of WT
versus the vhs mutant HSV-1 are alleviated in interferon receptor
defective (IFNAR KO) mice, suggesting that vhs-induced suppression
of the innate immune response contributes to viral ﬁtness (Leib et al.,
1999; Smiley, 2004).
Selective inactivation of the muSOX mRNA degradation activity
leads to a severe attenuation of MHV68 in B cells during the phase
of peak latency establishment (Richner et al., 2011). This could be
due to improper immune evasion and/or cell-type speciﬁc replication
defects, as the muSOX mutant virus replicates to WT titers in the
mouse lung but trafﬁcs inefﬁciently to B cells and displays cell type
speciﬁc replication defects in cultured cells (Abernathy et al., 2014;
Richner et al., 2011). Similar to the ability of vhs to degrade immune
modulatory mRNAs, EBV BGLF5 also reduces expression of immune
molecules, in particular HLA I and II (Rowe et al., 2007; Zuo et al.,
2008). However, this activity is redundant with other EBV proteins
that speciﬁcally combat HLA processing and transport and thus
appears to have only a small effect on CD8þ T cell recognition
(Quinn et al., 2014). Whether CD8þ T cell recognition or innate
immune signaling are inﬂuenced bymRNA degradation during in vivo
infection with other gamma-herpesviruses remains to be determined.
Both VACV decapping mutants and CoV nsp1 mutants also
display altered virulence phenotypes, although further research is
needed to determine the extent to which these are directly linked to
mRNA degradation. Mice infected with VACV D10 stop and catalytic
mutants show less weight loss and mortality compared to a WT
infection, and these mutant viruses replicate to lower titers in all
organs (Liu et al., 2014). Although there is not in vivo data for nsp1 of
SARS CoV, the nsp1 protein of the coronavirus mouse hepatitis virus
(MHV) retains the mRNA degradation function, as well as several
additional roles in inhibiting immune signaling pathways. These
activities align well with the observation that an MHV nsp1 deletion
virus is severely attenuated in WT mice, but is completely rescued in
IFNAR KO mice (Zust et al., 2007). Determining the extent to which
nsp1-induced virulence links to its host shutoff activity will require
the use of single function nsp1 mutants selectively defective for
mRNA cleavage or immune pathway impairment. In this regard, the
recent characterization of a panel of SARS CoV nsp1 mutants that
exhibit selective functional defects should help determine the
contribution of mRNA degradation to the nsp1 virulence phenotypes
(Jauregui et al., 2013).
Fig. 2. Virus-induced mRNA degradation impacts RNA processing. (A) Widespread mRNA degradation in the cytoplasm leads to release of PABPC from poly(A) tails. This
exposes its NLS, which is normally masked during RNA binding, leading to nuclear import via interactions with importin α. (B) Nuclear accumulation of PABPC promotes
hyperadenylation of nascent transcripts via PAP II and an mRNA export block.
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New roles for cellular nucleases in counteracting viral infection
The use of RNA-targeting nucleases is also a component of many
of the cellular antiviral defense pathways, some of which play dual
roles in regulating normal cellular metabolism and viral restriction
(Fig. 3). For example, in addition to its well-established role in
eliminating PTC-containing mRNA, the NMD pathway has recently
been shown to function in the restriction of positive strand (þ) RNA
viruses in plants and in mammalian cells (Balistreri et al., 2014;
Garcia et al., 2014). A genetic screen uncovered the central NMD
effector Upf1 as a cellular restriction factor of the plant (þ) RNA
viruses Potato virus X (PVX) and Turnip crinkle virus (TCV) (Garcia
et al., 2014). NMD-based restriction is hypothesized to act upon the
input genomic viral RNA undergoing initial rounds of translation, and
thus might function before the onset of RNAi, the major antiviral
pathway in plants. One of the known activators of NMD is an
unusually long 30 UTR on the target mRNA, as this can be associated
with less efﬁcient translation termination (Inada, 2013; Kervestin
and Jacobson, 2012). In this regard, many (þ) RNA plant viruses
encode subgenomic (sg) RNAs, which creates the appearance of a
long 30 UTR on the genomic mRNA and select sgRNAs. Indeed, these
long 30 UTRs are required for degradation of PVX and TCV RNAs via
NMD, conﬁrming that intrinsic features of viral RNAs render them
susceptible to cellular QC pathways (Garcia et al., 2014).
In mammalian cells, depleting NMD factors Upf1, Smg5, or
Smg7 leads to increased replication of the alphaviruses Semliki
Forest virus (SFV) and Sindbis virus (SINV), suggesting that NMD
may target viral genomic RNA for degradation (Balistreri et al.,
2014). Unexpectedly, although like PVX and TCV these viruses
have long 30 UTRs, deletion of the long 30 UTR of SFV does not alter
the restriction by Upf1 (Balistreri et al., 2014). Furthermore, viral
restriction does not require the NMD endonuclease Smg6. Thus,
the mechanism of decay and the viral RNA feature(s) that trigger
virus-induced activation of NMD in mammalian cells remain to be
elucidated. However, a broader role for NMD in controlling
mammalian viruses is supported by the fact that multiple
retroviruses have evolved mechanisms to restrict NMD. This can
occur through inhibitory interactions with NMD components or
through viral RNA sequences that protect against NMD (Mocquet
et al., 2012; Withers and Beemon, 2010).
In plants and insects, RNA interference (RNAi) is the primary
antiviral defense mechanism. The RNAi pathway restricts gene
expression by processing the long double stranded RNAs frequently
generated during viral replication into short interfering RNAs (siR-
NAs), which guide endonucleolytic cleavage of complementary target
mRNAs. Although mammalian cells possess the RNAi machinery, in
most cases RNAi does not appear to play a signiﬁcant antiviral role,
and has instead been supplanted by the protein-based interferon
response (Cullen, 2014). However, recent data reveal that in select cell
types such as ES cells, RNAi indeed functions in an antiviral capacity
(Li et al., 2013; Maillard et al., 2013). One hypothesis is that an
antiviral role for RNAi is retained in these cells because they lack a
fully functional interferon response. Furthermore, mice express an
oocyte-speciﬁc N-terminally truncated isoform of the nuclease
responsible for generating mature forms of the effector small RNAs
(miRNAs or siRNAs), termed Dcr1 (Flemr et al., 2013). Dcr1 has
increased siRNA-processing activity relative to the full-length Dcr
nuclease, perhaps explaining why undifferentiated cells contain RNAi-
based antiviral activity (Cullen, 2014; Flemr et al., 2013). Because Dcr1
is not expressed in primates, whether similar RNAi-based antiviral
activity is active in human ES cells remains an open question.
The interferon (IFN) pathway is the primary effector of the
mammalian innate immune response, and its activation can induce
the expression of proteins that drive either selective destruction of
viral RNA or more indiscriminate destruction of viral and cellular RNA.
An example of the former is the zinc-ﬁnger antiviral protein (ZAP),
which binds speciﬁcally to viral RNAs that contain a ZAP response
element (ZRE). Upon binding to viral RNA, ZAP recruits cellular RNA
decay machinery, including the deadenylase PARN, the RNA 30–50-
directed exonuclease complex called the exosome, and the Dcp1/2
decapping enzymes via their p72 helicase co-factor (Zhu et al., 2011).
Many, but not all viruses, contain ZREs and are restricted by ZAP,
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Fig. 3. Cellular nucleases with antiviral roles. (A) Viral RNA of (þ) RNA viruses can be recognized by cellular QC pathways like NMD, in some cases due to long 30 UTRs which
are inherent to subgenomic RNAs (sgRNA). This leads to their degradation by Smg6 and perhaps other nucleases. (B) RNAi cleaves viral dsRNA, which is loaded into a RNA
induced silencing complex (RISC) that targets viral RNA for endonucleolytic cleavage by Ago. (C) IFN-activated mRNA degradation pathways include ZAP and RNase L. ZAP
binds viral RNA at speciﬁc response elements (ZRE) and recruits cellular decay factors, including deadenylase PARN, de-capping enzyme Dcp1, and the 30–50 exosome. IFN
also induces 2–5A synthase (OAS) to synthesize the RNase L activator 2–5A, leading to RNase L dimerization and cleavage of viral and cellular RNAs.
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including HIV, ﬁloviruses, Sindbis virus, and MHV68 (Bick et al., 2003;
Muller et al., 2007; Xuan et al., 2013; Zhu et al., 2011). Zap contains
four CCCH-type zinc ﬁngers in its N-terminal domain that speciﬁcally
bind RNA and recruit decay factors (Zhu et al., 2011; Zhu and Gao,
2008). As with many other mRNA decay pathways, ZAP-induced
degradation is preceded by inhibition of mRNA translation. ZAP
restricts translation of its target mRNAs by interacting with the eIF4A
helicase in a manner that disrupts the ability of eIF4A to associate
with eIF4G (Zhu et al., 2012). Translational repression appears
selective for ZRE-containing transcripts, suggesting that ZAP only
binds eIF4A associated with its target mRNAs (Zhu et al., 2012).
Unlike the ZRE-speciﬁc targeting of ZAP, the IFN-activated cellular
endonuclease RNase L cleaves a much broader spectrum of RNAs.
RNase L is inactive as a monomer, but becomes active upon binding
20–50 oligoadenylates (2–5A) that are produced by another IFN-
induced protein, 2–5A synthase (OAS). Binding of 2–5A allosterically
activates RNase L by inducing its dimerization, whereupon it cleaves
both viral and cellular RNAs, usually at a 50-UNN-30 consensus
(Bhattacharyya, 2014; Han et al., 2014). That said, two features of
RNase L might cause it to favor viral over cellular mRNAs. First, the
UU/UA dinucleotides that often make up the RNaseL cleavage site are
relatively rare in the coding regions of cellular mRNAs, possibly as an
evolutionary trend to avoid RNase L cleavage (Al-Saif and Khabar,
2012). Second, cellular RNAs contain a variety of nucleoside mod-
iﬁcations, some of which confer increased resistance to RNase L
(Anderson et al., 2011). Not surprisingly, many viruses have evolved
mechanisms to counteract the activation of RNase L, including
blocking IFN induction and directly disrupting 2–5A production
(Bhattacharyya, 2014; Silverman and Weiss, 2014).
Conclusions
The expanding number of viruses shown to exert control over the
cytoplasmic mRNA population through the activity of virally encoded
endonucleases or by activating cellular nucleases highlights the
importance of this process in diverse viral lifecycles. Although we
have highlighted select examples of viral endonucleases that pro-
mote mRNA decay, many other viruses impact RNA fate by inactivat-
ing mRNA degradation enzymes, hijacking or competing with the
cellular decay machinery, and relocalizing cellular proteins that
control mRNA stability (Moon and Wilusz, 2013).
Furthermore, as is frequently the case in virology, the study of
this virus–host interplay is sure to offer new insights into the
regulation of cellular RNA decay pathways. The ﬁeld is now
beginning to uncover how cellular RNA degradation enzymes with
central roles in basal and QC-associated RNA decay are also key
contributors to the antiviral response. Yet, in some cases the
precise players or their regulation may differ from their previously
characterized roles in the context of uninfected cells. In this
regard, revealing how viral RNAs are recognized and marked for
degradation by pathways such as NMD remains an important
endeavor. This should simultaneously provide insight into cellular
RNA features that impact QC surveillance, especially given the
numerous parallels between mRNA degradation by viruses and
cellular QC pathways. Furthermore, additional research is required
to deﬁne the importance of RNAi in the mammalian antiviral
response, including the cell context in which it operates as well as
whether it plays antiviral roles in primates.
Much remains to be discovered about the mechanisms under-
lying mRNA targeting by viral endonucleases as well. Questions
surrounding the precise roles of translation factors in recruiting or
activating nucleases, what sequence elements and context confer
cleavage, as well as how active translation impacts targeting all
remain active areas of research. Finally, although the data all point to
important roles for virus-induced mRNA degradation in replication
and immune evasion in vivo, very little is known about the relative
importance of regulating host versus viral mRNA abundance in these
processes. Ongoing and future research should provide answers to
these questions, as well as reveal the impact of virus-induced mRNA
degradation on a diversity of other cellular processes.
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